ECSP088730A - DIBENCILAMINE DERIVATIVES AS CETP INHIBITORS - Google Patents
DIBENCILAMINE DERIVATIVES AS CETP INHIBITORSInfo
- Publication number
- ECSP088730A ECSP088730A ECSP088730A ECSP088730A EC SP088730 A ECSP088730 A EC SP088730A EC SP088730 A ECSP088730 A EC SP088730A EC SP088730 A ECSP088730 A EC SP088730A
- Authority
- EC
- Ecuador
- Prior art keywords
- cholesterol
- derivatives
- compounds
- dibencilamine
- cetp inhibitors
- Prior art date
Links
- 239000003354 cholesterol ester transfer protein inhibitor Substances 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 4
- 235000012000 cholesterol Nutrition 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 230000036470 plasma concentration Effects 0.000 abstract 2
- 150000003626 triacylglycerols Chemical class 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical class C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 abstract 1
- 108010023302 HDL Cholesterol Proteins 0.000 abstract 1
- 108010010234 HDL Lipoproteins Proteins 0.000 abstract 1
- 102000015779 HDL Lipoproteins Human genes 0.000 abstract 1
- 108010028554 LDL Cholesterol Proteins 0.000 abstract 1
- 238000008214 LDL Cholesterol Methods 0.000 abstract 1
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
RESUMENCompuestos de dibencilamina y derivados, composiciones farmacéuticas que contienen estos compuestos y el uso de estos compuestos para elevar los niveles plasmáticos de ciertos lípidos, incluyendo el colesterol asociado a lipoproteínas de alta densidad y para reducir los niveles plasmáticos de otros lípidos, tales como el colesterol LDL y los triglicéridos y, por consiguiente, para tratar enfermedades que se exacerban por bajos niveles de colesterol-HDL y/o altos niveles de colesterol-LDL y triglicéridos, tales como aterosclerosis y enfermedades cardiovasculares en algunos mamíferos, incluyendo seres humanos.SUMMARY Dibenzylamine compounds and derivatives, pharmaceutical compositions containing these compounds and the use of these compounds to raise plasma levels of certain lipids, including cholesterol associated with high-density lipoproteins and to reduce plasma levels of other lipids, such as cholesterol LDL and triglycerides and, therefore, to treat diseases that are exacerbated by low levels of HDL-cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78148806P | 2006-03-10 | 2006-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP088730A true ECSP088730A (en) | 2008-10-31 |
Family
ID=40459931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP088730 ECSP088730A (en) | 2006-03-10 | 2008-09-10 | DIBENCILAMINE DERIVATIVES AS CETP INHIBITORS |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN101437803A (en) |
| EC (1) | ECSP088730A (en) |
| ZA (1) | ZA200807106B (en) |
-
2007
- 2007-02-28 CN CNA2007800165055A patent/CN101437803A/en active Pending
-
2008
- 2008-08-18 ZA ZA200807106A patent/ZA200807106B/en unknown
- 2008-09-10 EC ECSP088730 patent/ECSP088730A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101437803A (en) | 2009-05-20 |
| ZA200807106B (en) | 2009-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2007000044A (en) | DIBENCILAMINE COMPOUNDS AND DERIVATIVES | |
| UY28243A1 (en) | QUINOLINE AND QUNOXALINE COMPOUNDS | |
| BRPI0518476A2 (en) | dibenzyl amine compounds and derivatives | |
| BR112015026513A2 (en) | n-piperidin-3-ylbenzamide derivatives to treat cardiovascular disease | |
| CL2012001124A1 (en) | Pharmaceutical composition comprising a concentrated therapeutic extract, comprising phospholipids in a concentration of 60 to 99% and used to treat cardiovascular diseases, reduce triglyceride levels, reduce LDL cholesterol and increase HDL cholesterol. | |
| MX2015015234A (en) | COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN (a) EXPRESSION. | |
| UY28097A1 (en) | PPAR ACTIVATORS | |
| CR9012A (en) | 4-AMINO-SUBSTITUTED-2-SUBSTITUTED-1,2,3,4-TETRAHYDROQUINOLINE COMPOUNDS | |
| NI201400042A (en) | 2 - THIOPYRIMIDINONES | |
| CO2018002198A2 (en) | Pharmaceutical compositions comprising an oligomeric compound to modulate the expression of apolipoprotein (a) | |
| ECSP088729A (en) | DIBENCILAMINE COMPOUNDS AND DERIVATIVES | |
| UY36346A (en) | AMIDA SUBSTITUTED COMPOUNDS | |
| ECSP088730A (en) | DIBENCILAMINE DERIVATIVES AS CETP INHIBITORS | |
| CU20080164A7 (en) | DIBENCILAMINE COMPOUNDS AND DERIVATIVES | |
| DOP2005000179A (en) | QUINOLINE COMPOUND | |
| TW200616964A (en) | Quinoline compounds | |
| UY29123A1 (en) | 4-AMINO-SUBSTITUTED-2-SUBSTITUTED-1,2,3,4-TETRAHYDROQUINOLINE COMPOUNDS | |
| DOP2005000182A (en) | 4-AMINO-SUBSTITUTED-2-SUBSTITUTED-1,2,3-TETRAHYDROQUINOLINE COMPOUNDS | |
| DOP2005000238A (en) | COMPOUNDS AND DERIVATIVES OF DIBENCIL AMINA | |
| DOP2004000863A (en) | QUINOLINE AND QUINOXALINE COMPOUNDS | |
| DOP2002000327A (en) | PPAR AGONISTS | |
| UY27158A1 (en) | PPAR COMPOUNDS | |
| UY27168A1 (en) | PPAR AGONISTS | |
| DOP2002000331A (en) | PPAR COMPOUND | |
| DOP2003000762A (en) | PPAR ACTIVATORS |